Publicaciones en colaboración con investigadores/as de University of Zurich (18)

2024

  1. A novel mouse model for familial hypocalciuric hypercalcemia (FHH1) reveals PTH-dependent and independent CaSR defects

    Pflugers Archiv European Journal of Physiology, Vol. 476, Núm. 5, pp. 833-845

2023

  1. Blocking FGF23 signaling improves the growth plate of mice with X-linked hypophosphatemia

    The Journal of endocrinology, Vol. 259, Núm. 1

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

2022

  1. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86

  2. Cellular and Molecular Alterations Underlying Abnormal Bone Growth in X-Linked Hypophosphatemia

    International Journal of Molecular Sciences, Vol. 23, Núm. 2

  3. Erratum: Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels (Pharmacopsychiatry (2022) 55 2 (73-86))

    Pharmacopsychiatry

  4. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

  5. Utility and validity of the Brief Psychiatric Rating Scale (BPRS) as a transdiagnostic scale

    Psychiatry Research, Vol. 314

2021

  1. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  2. Mind the gap versus filling the gap. The heart beyond specialties

    Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 213-215

2020

  1. Real-Time Assessment of Stress and Stress Response Using Digital Phenotyping: A Study Protocol

    Frontiers in Digital Health, Vol. 2

2019

  1. Assessing the severity of functional impairment of psychiatric disorders: Equipercentile linking the mini-ICF-APP and CGI

    Health and Quality of Life Outcomes, Vol. 17, Núm. 1

  2. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

    Nature Genetics

  3. Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia

    Schizophrenia Bulletin, Vol. 45, Núm. 2, pp. 305-314

  4. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

    Nature Genetics, Vol. 51, Núm. 3, pp. 414-430

  5. MAPK inhibition and growth hormone: a promising therapy in XLH

    FASEB Journal, Vol. 33, Núm. 7, pp. 8349-8362

2014

  1. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

    PLoS ONE, Vol. 9, Núm. 6

2013

  1. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

    Nature Genetics, Vol. 45, Núm. 12, pp. 1452-1458